News

PRESS RELEASES

Jan 9, 2026

Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases

Jan 9, 2026

IN THE NEWS

Mar 1, 2026

Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye

Mar 1, 2026
Cell & Gene

Feb 17, 2026

Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.

Feb 17, 2026
Forbes

Feb 12, 2026

Biotech CEOs discuss the state of the industry, what is needed to compete globally, the importance of having a patient-centric approach, and more

Feb 12, 2026
Biotech TV

Jan 21, 2026

JPM 2026: Aurora Therapeutics’ Edward Kaye on Scalable Personalized Gene Editing

Jan 21, 2026
Inside Precision Medicine

Jan 9, 2026

Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies

Jan 9, 2026
BioPharma Dive

Jan 9, 2026

Key scientist from Baby KJ team launches startup to scale personalized CRISPR medicines

Jan 9, 2026
STAT

Jan 9, 2026

Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments

Jan 9, 2026
Wired

Jan 9, 2026

Gene editing pioneers launch first startup focused on custom CRISPR therapies

Jan 9, 2026
Endpoints News

Jan 9, 2026